The survey indicated that GLP-1 users are changing their behavior, with more than half reported decreased appetite, 40% fewer food cravings, around 30% less frequent restaurant or take-out spending, and about 35% smaller portions, "lighter" choices or not finishing meals
Musculoskeletal toxicities usually include myalgias, arthralgias with elevated muscle enzymes signifying significant muscle destruction [26, 27]
Retatrutide controls energy in and energy out
Semaglutide (GLP-1) and Low-Dose Naltrexone for Weight Loss Semaglutide From the start of the COVID-19 pandemic, obesity is apparent as a risk factor for severe COVID-19 illness
Competing interests The authors declare no competing interests
Thus, we used one of the simplest available models, logistic regression, as the benchmark